INAF.JK
Price:
$126
Market Cap:
$390.51B
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2001-04-18
Stock Exchange
JKT
Ticker
INAF.JK
According to PT Indofarma Tbk’s latest financial reports and current stock price. The company's current PE Ratio is -0.56. This represents a change of -74.52% compared to the average of -2.20 of the last 4 quarters.
The mean historical PE Ratio of PT Indofarma Tbk over the last ten years is 45.22K. The current -0.56 PE Ratio has changed -100.12% with respect to the historical average. Over the past ten years (40 quarters), INAF.JK's PE Ratio was at its highest in in the December 2018 quarter at 2.13K. The PE Ratio was at its lowest in in the June 2021 quarter at -2796.62.
Average
45.22K
Median
-5.41
Minimum
-835.20
Maximum
452.85K
Discovering the peaks and valleys of PT Indofarma Tbk PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 133.60%
Maximum Annual PE Ratio = 452.85K
Minimum Annual Increase = -10785.43%
Minimum Annual PE Ratio = -835.20
Year | PE Ratio | Change |
---|---|---|
2023 | -2.49 | -70.03% |
2022 | -8.32 | -95.48% |
2021 | -183.95 | -100.04% |
2020 | 452.85K | 133.60% |
2019 | 338.70 | -155.04% |
2018 | -615.39 | 55.76% |
2017 | -395.08 | -52.70% |
2016 | -835.20 | -1153.94% |
2015 | 79.25 | -91.52% |
2014 | 934.21 | -10785.43% |
The current PE Ratio of PT Indofarma Tbk (INAF.JK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-64.92
5-year avg
90.60K
10-year avg
45.22K
PT Indofarma Tbk’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PT Indofarma Tbk using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like PT Indofarma Tbk or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is PT Indofarma Tbk's PE Ratio?
How is the PE Ratio calculated for PT Indofarma Tbk (INAF.JK)?
What is the highest PE Ratio for PT Indofarma Tbk (INAF.JK)?
What is the 3-year average PE Ratio for PT Indofarma Tbk (INAF.JK)?
What is the 5-year average PE Ratio for PT Indofarma Tbk (INAF.JK)?
How does the current PE Ratio for PT Indofarma Tbk (INAF.JK) compare to its historical average?